Pharmaco-Imaging in Drug and Biologics Development (eBook)

Fundamentals and Applications
Artikelnummer: 978-1-4614-8247-5
Einband: PDF
Verfügbarkeit: Download, sofort verfügbar (Link per E-Mail)
CHF 176.50
decrease increase

Advances in drugs and biologics to mitigate or cure some of nature's most complex medical problems have been incredible to behold.  These accomplishments are due to the actions of a wide theatre of participants from biologists, pharmacologists, geneticists, chemists and manufacturers, molecular biologists, toxicologists, clinicians, nurses, program managers, quality assurance personnel, regulatory professionals and - a new group of innovators - the Imaging Scientists.  Imaging has grown from the microscopy sections put on slides with special stains to now in vivo "slices" created with innovative physics, imaging tracers and contrast agents, and incredibly fast and accurate computational systems.  The world of biology has become one of witnessing the actions of drugs and biologics through the window of mechanical and electrical engineering - creating  instruments and reporter molecules that can help us "see" into our bodies and "paint" them with medical information needed to resolve disease. This book will inspire imagination and elicit even more innovations in the development of new and novel drugs and biologics through imaging.


Advances in drugs and biologics to mitigate or cure some of nature's most complex medical problems have been incredible to behold.  These accomplishments are due to the actions of a wide theatre of participants from biologists, pharmacologists, geneticists, chemists and manufacturers, molecular biologists, toxicologists, clinicians, nurses, program managers, quality assurance personnel, regulatory professionals and - a new group of innovators - the Imaging Scientists.  Imaging has grown from the microscopy sections put on slides with special stains to now in vivo "slices" created with innovative physics, imaging tracers and contrast agents, and incredibly fast and accurate computational systems.  The world of biology has become one of witnessing the actions of drugs and biologics through the window of mechanical and electrical engineering - creating  instruments and reporter molecules that can help us "see" into our bodies and "paint" them with medical information needed to resolve disease. This book will inspire imagination and elicit even more innovations in the development of new and novel drugs and biologics through imaging.


Schreiben Sie Ihre eigene Bewertung
  • Nur registrierte Benutzer können Produkte bewerten
*
*
Schlecht
Sehr gut
*
*
*
*
VerlagSpringer US
EinbandPDF
Erscheinungsjahr2013
Seitenangabe401 S.
AusgabekennzeichenEnglisch
AbbildungenXVII, 401 p. 125 illus., 101 illus. in color.
Masse13'010 KB
PlattformPDF
ReiheAAPS Advances in the Pharmaceutical Sciences Series; Biomedical and Life Sciences; Biomedical and Life Sciences
AutorMoyer, Brian R. (Hrsg.) / Cheruvu, Narayan P. S. (Hrsg.) / Hu, Tom C. -C. (Hrsg.)

Alle Bände der Reihe "AAPS Advances in the Pharmaceutical Sciences Series; Biomedical and Life Sciences; Biomedical and Life Sciences (R0)"

Über den Autor Brian R. (Hrsg.) Moyer

Mr. Brian R. Moyer is Owner/President of BRMoyer & Associates, LLC, Bedford, NH, consulting in medical imaging, radiation/chemical injury, and PK/TK services. He is under contract as a Sr. Science Advisor for HHS/BARDA, Washington, D.C., for Radiation-Chem countermeasure development. Mr. Moyer earned an M.S. in Pharmacology (Univ. of California, San Francisco), an M.S. in Toxicology (Univ. of San Francisco), and is board-certified in Nuclear Medicine Technology (CNMT).  He has over 40 years in the imaging field with over 80 publications and has contributed toward six drug approvals. Dr. Narayan Cheruvu is Sr. Principal Clinical Pharmacologist at Covidien, St.Louis, MO.  He earned a B.S. in Pharmacy (Andhra Univ.), an M.S. in Pharmacy (Institute of Technology-Banaras Hindu Univ., India) and a Ph.D. in Pharmaceutical Science (Nebraska Medical Center, Omaha, NE).  Dr Cheruvu has more than 9 years in preclinical/clinical pharmacology, more than 20 publications and has contributed toward three drug approvals. Dr. Tom C.-C. Hu is a Project Officer at HHS/BARDA, Washington D.C., overseeing contracts for Radiation-Chem countermeasure development and rapid radiation biodosimetry. He is an Asst. Professor of Radiology (Medical College of Georgia) and served as Principal Scientist at GlaxoSmithKline PLC.  Dr. Hu earned a B.S. in Chemistry (Univ. Pittsburgh), an M.S. and Ph.D. in Chemistry (Carnegie Mellon Univ), and an M.B.A (Villanova Univ).

Weitere Titel von Brian R. (Hrsg.) Moyer

Produktbewertungen
Nur registrierte Benutzer können Produkte bewerten